Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 4 4Phase 3 2Phase 1/2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 2Menstruation Disturbances 1

Interventions

Metformin 21Letrozole 11Clomiphene 7dapagliflozin 4Contraceptives, Oral 4Chorionic Gonadotropin 4cetrorelix 3Liraglutide 3Inositol 3follitropin beta 2follitropin alfa 2drospirenone and ethinyl estradiol combination 2Musculoskeletal Manipulations 2Glycoprotein Hormones, alpha Subunit 2DLBS3233 2Cholecalciferol 2semaglutide 1saxagliptin 1lime 1follicle stimulating hormone, human, with HCG C-terminal peptide 1drospirenone 1cinnulin PF 1Urofollitropin 1Triptorelin Pamoate 1Treatment Expectations 1Thioctic Acid 1Tamoxifen 1Tablets 1Sugars 1Sperm Injections, Intracytoplasmic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Polycystic Ovary Syndrome × drospirenone and ethinyl estradiol combination × Clear all
NCT00714233 2015-05-15

Treatment of Adolescent Polycystic Ovary Syndrome (PCOS)

University of Rochester

Phase 3 Completed
43 enrolled 13 charts

Menstruation Disturbances, Polycystic Ovary Syndrome

NCT01581814 2012-04-20

Effects of Drospirenone-ethinylestradiol and/or Metformin on Cardiovascular Risk in Hyperinsulinemic Women With Polycystic Ovary Syndrome

Catholic University of the Sacred Heart

Phase 3 Completed
99 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡